Metlife Inc (MET) concluded trading on Thursday at a closing price of $85.88, with 3.15 million shares of worth about $270.39 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 22.62% during that period and on December 05, 2024 the price saw a gain of about 0.59%. Currently the company’s common shares owned by public are about 693.65M shares, out of which, 579.88M shares are available for trading.
Stock saw a price change of -2.69% in past 5 days and over the past one month there was a price change of 9.89%. Year-to-date (YTD), MET shares are showing a performance of 29.87% which increased to 34.25% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $63.19 but also hit the highest price of $89.05 during that period. The average intraday trading volume for Metlife Inc shares is 3.23 million. The stock is currently trading 1.65% above its 20-day simple moving average (SMA20), while that difference is up 2.74% for SMA50 and it goes to 13.98% higher than SMA200.
Metlife Inc (NYSE: MET) currently have 693.65M outstanding shares and institutions hold larger chunk of about 75.01% of that.
The stock has a current market capitalization of $59.47B and its 3Y-monthly beta is at 1.05. PE ratio of stock for trailing 12 months is 17.32, while it has posted earnings per share of $4.96 in the same period. Its PEG reads 1.32 while making debt-to-equity ratio of 0.63. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MET, volatility over the week remained 1.61% while standing at 1.73% over the month.
Stock’s fiscal year EPS is expected to rise by 14.13% while it is estimated to increase by 17.19% in next year. EPS is likely to grow at an annualized rate of 13.14% for next 5-years, compared to annual growth of -18.10% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by TD Cowen on October 09, 2024 offering a Buy rating for the stock and assigned a target price of $97 to it. Coverage by Barclays stated Metlife Inc (MET) stock as an Overweight in their note to investors on September 05, 2024, suggesting a price target of $91 for the stock. On January 08, 2024, Goldman Upgrade their recommendations, while on November 17, 2023, Barclays Resumed their ratings for the stock with a price target of $71. Stock get a Hold rating from Deutsche Bank on October 05, 2023.
